Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effects of Tysabri over 12 months on multiple sclerosis (MS) related fatigue in patients with relapsing remitting multiple sclerosis (RRMS) (TYNERGY)
Control of microglial neurotoxicity by the fractalkine receptor.
[Sarcoid neuropathy].
Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?
No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy.
Neural stem/progenitor cells differentiate into oligodendrocytes, reduce inflammation, and ameliorate learning deficits after transplantation in a mouse model of traumatic brain injury.
Structural correlates for fatigue in early relapsing remitting multiple sclerosis.
Misfiring in multiple sclerosis: Cerebellar Channelopathy, a Potential Novel Target?
Re: S Shahrbanian, M Auais, P Duquette, K Anderson, NE Mayo. Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis. Pain Res Manag 2013;18(5):e94-e100.
Chemotactic signaling and beyond: link between interleukin-16 and axonal degeneration in multiple sclerosis.
Is there a (host) genetic predisposition to progressive multifocal leukoencephalopathy?
Hilbert-Huang transform based instrumental assessment of intention tremor in multiple sclerosis.
Identification of genetic determinants of the sexual dimorphism in CNS autoimmunity.
Correction: The Extracellular Domain of Myelin Oligodendrocyte Glycoprotein Elicits Atypical Experimental Autoimmune Encephalomyelitis in Rat and Macaque Species.
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Daily fingolimod administration may cause lymphopenia but alternate-day administration may be too little to inhibit disease activity.
Rituximab in Turkish neuromyelitis optica patients with limited response to other immunosuppressants.
Mouse Hepatitis Virus infection remodels Connexin43 mediated gap junction intercellular communication both in vitro and in vivo.
Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Inhibin-a immunoreactivity in nervous system lesions.
Response to Comment on "Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2".
[Do new oral therapies show advantages in the basal therapy of multiple sclerosis? Con.]
Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.

Pages